Institut réginal du Cancer de Montpellier
Montpellier, 34298, France
NCT Number: NCT03253159
Evaluate the impact of the support in reducing postoperative adverse events in particular on the pain but also on anxiety, comfort, nausea, vomiting, and fatigue.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Montpellier, 34298, France
Drug premedication with anxiolytics (benzodiazepine or equivalent) are usually prescribed to alleviate patient anxiety. However, alternative techniques, additional non-pharmacological, have proven effective in alleviating pain and anxiety perioperative. These techniques are retained relaxation therapy, reinsurance, breathing techniques and medical hypnosis as a technique of choice. Regarding medical hypnosis techniques, many studies have shown that performing a hypnotic technique performed perioperative could reduce the doses of anesthetics, postoperative pain, length of stay in the post room Interventional (SSPI) and a number of postoperative adverse effects.
Among the various techniques of hypnosis that can be offered to patients in the perioperative, conversational hypnosis is to accompany the patient on admission to the block to realization of general anesthesia. This technique aims to suggest a pleasant environment and not anxiety.
This study evaluate the impact of this support in reducing postoperative major adverse effects in particular on the pain but also on anxiety, comfort, nausea, vomiting, and fatigue.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The conversational hypnosis (10-15 min) is standardized and performed just before intravenous general anesthesia induction in the operative room.
Time frame: through study completion, an average of 5 year
Pain intensity assessment
Time frame: through study completion, an average of 5 year
Reduction of the pain adverse postoperative outcome:
Using Visual Analogic Scale (VAS > 3/10)
Institut du Cancer de Montpellier - Val d'Aurelle
Other
Added Conversational Hypnosis Reduced General Anesthesia Side Effects for Day Case Breast Surgery: A Prospective Randomized Phase III Clinical Trial (HYPNOSEIN)
Acronym: HYPNOSEIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06234488
Breast Adenocarcinoma, Breast Cancer
Los Angeles, California, United States
View Trial DetailsNCT03949946
Breast Cancer, Breast Diseases
Aberdeen, Aberdeenshire, United Kingdom
View Trial DetailsNCT05176860
Breast Cancer, Breast Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsNCT03644186
Breast Cancer, Breast Diseases
Brasschaat, Belgium
View Trial Details